Product Reliability Sample Clauses

Product Reliability. Buyer will share with Seller service history and product reliability data which is readily available to Buyer concerning the performance of Seller's products.
AutoNDA by SimpleDocs
Product Reliability. Buyer and Seller will share with each other service history and product reliability data which is readily available to Buyer concerning the performance of Seller’s products; provided that Seller agrees to treat all such data as confidential information of Buyer and shall not disclose any such data to any third party without Buyer’s prior written approval in accordance with Section 22 hereto.
Product Reliability. If any Product does not function at the mean time between failure rate (MTBF) set forth in Schedule D, both parties agree to review their respective failure rate data for such Product and to discuss what course of action, if any, would be appropriate to remedy such failure.
Product Reliability. SSI agrees to ensure that over the applicable warranty period for the Co-branded Products specified in Section 13 will meet the quality and reliability standards as defined by the Specifications and the Parameters ("RELIABILITY"). If over the Specifications' defined life of the Product, the Product(s) fail to meet the Reliability standards, then SSI shall use its reasonable commercial efforts to implement a corrective action plan and will deliver, if applicable, engineering change orders, packaging changes, test procedures, Software and Hardware changes, process changes that affect Form, Fit, Function, Reliability, Maintainability, Compatibility or Interoperability, [*] to StorageTek in order to achieve the Reliability standards. SSI will implement a corrective action plan pursuant to the response and escalation matrix set forth on SCHEDULE 2 OF EXHIBIT B (CO-BRANDED PRODUCT SERVICE AND SUPPORT AGREEMENT). Should the Products fail to meet the Reliability standards for [*], SSI's Vice President and General Manager of SSI Wichita will meet with StorageTek's Vice President of Quality in Louisville, Colorado to establish appropriate corrective actions.
Product Reliability. The Mean Time Between Failure (Herein referred to as “MTBF”) for the Products shall not be less than [CONFIDENTIAL] for the System, a failure being defined as a Malfunction of the software or hardware which totally prevents the use of the system for its fundamental clinical usage and when such malfunction cannot be recovered unless making the parts replacement / software upgrade by the authorized service engineers. Failures caused by normal wear and tear and user-induced damage will not be subject to this measurement. If the Reliability of the Products is lower than the above minimum targets, VC shall promptly submit to GEHC a written corrective action plan, which at a minimum contains an analysis of the root cause(s) and specific actions taken or planned to correct the reliability weakness, including but not limited to the development of an FMI as defined in Section 4.1.
Product Reliability. All parts should be designed and selected to give a minimum of 5 years service based on the machine working 18 hours per day for 320 days per year, subject to the routine maintenance schedule being carried out. The machine up time requirement shall be greater than 96% MTTR = 1 hr PRODUCT SETUP The machine shall be capable of configuring a new product in 15minutes or less. The process includes the following steps. * Screen load /unload. * Squeegee removal / replacement * Create board file * Completion of board file parameter pages. * Configure board tooling. It shall be possible to set up a pre-programmed product in 10 minutes or less. The process includes the following steps: * Select board file * Screen load /unload * Squeegee removal / replacement * Configure board tooling. MACHINE DIAGNOSTICS The machine shall have the capability to report the following * A comprehensive list of error conditions giving the machine operator a description of the condition and possible recovery messages. * Sensor Input and output status and check for correct operation * Motor status and check for correct operation SIGMALINK SigmaLink is an off-line facility is optionally available and enables the creation and storage of PCB files. These can be up- or down-loaded to the stencil printer as required.
Product Reliability. All parts should be designed and selected to give a minimum of 5 years service based on the machine working 18 hours per day for 320 days per year, subject to the routine maintenance schedule being carried out. The machine up time requirement shall be greater than 96% MTTR = 1 hr PRODUCT SETUP The machine shall be capable of configuring a new product in 15minutes or less. The process includes the following steps. * Screen load /unload. * Squeegee removal / replacement * Create board file * Completion of board file parameter pages. * Configure board tooling. It shall be possible to set up a pre-programmed product in 10 minutes or less. The process includes the following steps: * Select board file * Screen load /unload * Squeegee removal / replacement * Configure board tooling. PCB SUPPORT * The PCB to be printed will be held using edge clamps, the edge clamps will not encroach more than 3mm over two sides of the PCB. * The machine shall be supplied with manual tooling support. Both systems shall operate with the same pin design and be capable of handling 10 pins and 4 vacuum tooling supports.
AutoNDA by SimpleDocs
Product Reliability. All qualification and reliability testing shall be conducted at the Seller' site with representatives of the Buyer present at the Buyer's option. Buyer shall have full access to all reliability plans and test results data generated by Seller. These shall include, but not be limited to, MTBF predictions and associated environmental parameters, acceleration factors, component derating factors, stress test parameters, test conditions, test failures, number of unit hours, time to failure, failure modes and symptoms, root cause failure analysis, and resultant corrective actions. Summary reports of results for each phase of reliability testing shall be published and provided to the Buyer's Quality Assurance organization. Reliability Testing shall be accomplished in three phases: * Phase I shall assure that the product design is capable of achieving the inherent design reliability. * Phase II shall assure that the manufacturing process does not degrade the inherent design reliability. * Phase III shall assure that the reliability performance of the product design and the manufacturing process are maintained during volume production. It shall also serve as an ongoing process control point, with data provided to the Buyer. Buyer and Seller mutually agree to the content, format, and frequency of reporting as set forth in Section 3.4 below. Buyer reserves the right to review Seller's test plans for each phase of reliability testing, at lease one month prior to the start of that phase. If such review is conducted, Buyer's concerns shall be raised and resolved jointly with the Seller before each test phase can commence. Seller's plans will include mutually agreed-upon statistical confidence limits for each phase of testing, where applicable. The Seller shall be solely responsible to assure that the product design, third party vendor components, and manufacturing processes employed in the production of the product meet the product reliability requirements as set forth in the Product Specification (Buyer's Purchase/Engineering Specification). Seller shall further assure that any changes to the product design as a result of engineering change, vendor change, or process change do not adversely affect the reliability of the product as delivered to Buyer.

Related to Product Reliability

  • Reliability Reliability targets (Mean Time Between Failures (MTBF)) are defined in the technical specifications as set out in the Contract. Notwithstanding any possible application of penalties relating to reliability defined in the Contract, Goods shall remain covered by the warranty defined in this Article 16 as long as the reliability commitments have not been reached.

  • Product Quality 4.1 The following provisions shall apply to Product after Production:

  • Product Recalls The Company is not aware of any pattern or series of claims against the Company or any of its subsidiaries which reasonably could be expected to result in a generalized product recall relating to products sold by the Company or any of its subsidiaries, regardless of whether such product recall is formal, informal, voluntary or involuntary.

  • Product Recall (a) If a recall is required by applicable Law, or if Buyer or Supplier reasonably determines that a recall is advisable because the goods may create a potential safety hazard, are not in compliance with any applicable code, standard or legal requirement, or contain a defect or non-conformance with the requirements of this Order occurring or likely to occur in multiple goods, which such defects or non-conformances are substantially similar or have substantially similar causes or effects (collectively a “Serial Defect”), the parties shall promptly communicate such facts to each other. At Buyer’s request, Supplier shall promptly develop a corrective action plan satisfactory to Buyer, which shall include all actions required to recall and/or repair the goods and any actions required by applicable Law (“Corrective Action Plan”) for Buyer’s review and approval. At Buyer’s election, Xxxxx may develop the Corrective Action Plan. In no event shall Buyer and Supplier’s failure to agree on the Corrective Action Plan delay the timely notification of a potential safety hazard, non-compliance or Serial Defect to users of the goods, cause either party to be non-compliant with applicable Law or prevent Buyer from taking reasonable actions to prevent injury or damage to persons, equipment or other property. Supplier and Buyer shall cooperate with and assist each other in any corrective actions and/or filings, if applicable.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Quality Monitoring 4.2.1. To prepare a Quality Assurance (QA) Plan

  • Product Warnings As of the Effective Date, all Products CORE sells and/or distributes for sale in California which do not qualify as Reformulated Products, will bear a clear and reasonable warning pursuant to this Section. CORE further agrees that the warning will be prominently placed with such conspicuousness when compared with other words, statements, designs or devices as to render it likely to be read and understood by an ordinary individual under customary conditions of use. For purposes of this Settlement Agreement, a clear and reasonable warning for the Products shall consist of a warning affixed directly to the product or product packaging, label, or tag, for Products sold in California and containing one of the following statements: WARNING: Reproductive Harm- xxx.X00Xxxxxxxx.xx.xxx OR WARNING: This product can expose you to chemicals, including DEHP, which are known to the State of California to cause birth defects or other reproductive harm. For more information go to xxx.X00Xxxxxxxx.xx.xxx

  • PRODUCT MANUFACTURER'S SUPPLIERS Only those dealers/distributors listed by the manufacturer will be considered authorized to act on behalf of the Product Manufacturer.

  • Product Returns Client will have the responsibility for handling customer returns of the Products. Patheon will give Client any assistance that Client may reasonably require to handle the returns.

  • Quality Service Standards Price Services and the Fund may from time to time agree to certain quality service standards, as well as incentives and penalties with respect to Price Services’ Services hereunder.

Time is Money Join Law Insider Premium to draft better contracts faster.